Human Vaccines Against Infectious Diseases

Around 25% of deaths globally are attributed to infectious diseases, especially in children under the age of five. If the right tools could be put in place to ensure that all children get access to basic antibodies, regardless of their socioeconomic situation or geographic location, a major portion of the burden of incurable diseases could be lessened. Additionally, new safe and effective vaccines need to be developed for a variety of diseases for which neither a practical nor an accessible preventative intervention strategy exists. The general public, the corporate sector, and the humanitarian sectors must work together to ensure that these new or better antibodies are fully developed and made available to the underprivileged populations as soon as is practical.

  •  Hepatitis A

  • Hepatitis B

    Related Conference of Human Vaccines Against Infectious Diseases

    February 27-28, 2025

    8th International Conference on Vaccines and Immunology

    Paris, France
    April 28-29, 2025

    2nd Global Summit on Vaccines & Emerging Diseases

    Bali, Indonesia
    July 28-29, 2025

    43rd Euro Global Summit and Expo on Vaccines & Vaccination

    Aix-en-Provence, France
    September 18-19, 2025

    7th World Congress on Vaccine and Immunology

    Amsterdam, Netherlands
    October 06-07, 2025

    37th Annual Congress on Vaccine and Clinical Trials

    Vancouver, Canada

    Human Vaccines Against Infectious Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in